Jonathan E. Gold

Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY.

Amphion Capital Management LLC (Amphion Capital) is a venture capital firm subsidiary of Amphion Innovations Plc founded in 1995 by Richard Morgan and Robert Bertoldi. The firm is headquartered in New York.

Federated Investment Management Co. (FIMCO) is a mutual fund manager and SEC-registered investment advisor headquartered in Pittsburgh, Pennsylvania. The firm is a subsidiary of FII Holdings, Inc. and their ultimate parent is Federated Investors, Inc. (NYSE: FII). FIMCO offers domestic and international equity, fixed-income and money market mutual funds, as well as a variety of separate account options for a wide range of investors.

Amphion Capital Partners LLC used to create, develop and operate healthcare and technology companies in partnership with corporations, universities and others seeking to profitably commercialize intellectual property. Focusing on long-term growth and profitability, the company's management team had collectively created and developed more than 50 technology-driven companies in the information technology, physical and life sciences industries. In the physical and life sciences industries, these companies include Celgene, Medisense, Quidel, and SEQUUS. The company was headquartered in New York, NY.

FJC provides services to manage charitable giving. It offers following programs for philanthropic giving and assistance to non-profit organizations: FJC donor advised funds, FJC fiscal sponsorship program, collective giving funds, young philanthropist funds, designated fund accounts, FJC gift certificates, online account access, customized investment options for accounts that are eligible and giving to qualified charities abroad. The company was founded by Marty Silverman in 1995 and is headquartered in New York, NY.